Skip to content

JBIO JBIO Noncash Or Part Noncash Unpaid Offering Costs

Noncash Or Part Noncash Unpaid Offering Costs at other companies

HTF
Heartflow, Inc. Common StockHTFL
$2.33M+2,152%
AMB
Ambiq Micro, Inc.AMBQ
-$75K
Septerna, Inc. logo
Septerna, Inc.SEPN
$0-100%
Easterly Government Properties logo
Easterly Government PropertiesDEA
$3K-78.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$136K
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$0-100%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept ck0001798749:NoncashOrPartNoncashUnpaidOfferingCosts.

The official record: JBIO’s 10-K, filed March 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's noncash or part noncash unpaid offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's noncash or part noncash unpaid offering costs?
JBIO (JBIO) reported noncash or part noncash unpaid offering costs of $210K in Q4 2025.
How has JBIO's noncash or part noncash unpaid offering costs changed year-over-year?
JBIO's noncash or part noncash unpaid offering costs increased by 44.8% year-over-year, from $145K to $210K.
What does noncash or part noncash unpaid offering costs mean?
This reflects the portion of capital-raising costs that have been incurred but not yet settled in cash at the end of the reporting period. It highlights liabilities related to financing activities that will require future cash outflows. Monitoring this ensures a complete view of the total cost of capital beyond immediate cash payments.